Trial intelligence / Profile preview

Comparison of Gelatin, Ringer, and modern hydroxyethyl starch after CABG

IRCT138803061964N1Phase 2Completed

Sponsor
Rajaie Cardiovascular Medical and Research Center
Start
Jan 2008
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gelatin, ringer's solution, hetastarch in Chronic Coronary Syndrome (CCS), sponsored by Rajaie Cardiovascular Medical and Research Center. Started Jan 2008; status: completed.

02

Drugs

gelatinringer's solutionhetastarch
03

Conditions

Chronic Coronary Syndrome (CCS)

Beyond the preview

Go deeper on IRCT138803061964N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138803061964N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call